Trademark Overview
On Monday, March 30, 2026, a trademark application was filed for PEPIXSOL with the United States Patent and Trademark Office. The USPTO has given the PEPIXSOL trademark a serial number of 99732666. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 30, 2026. This trademark is owned by Beijing Jingtai Technology Co., Ltd.. The PEPIXSOL trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Data processing apparatus; Recorded computer programs for use in the field of biotechnological research, drug discovery and pharmaceutical drug development; Computer operating programs, recorded; Downloadable computer software platforms for application development; Recorded computer operating software; Recorded computer operating system software; Downloadable computer operating programs; Downloadable computer operating programs and computer operating systems; Downloadable computer software using artificial intelligence (AI) for use in biotechnological research, drug discovery and pharmaceutical drug development; Downloadable software using artificial intelligence (AI) for writing content based on a theme; Computers; Downloadable operating system programs; Recorded operating system programs; Recorded computer software platforms for biotechnological research, drug discovery and pharmaceutical drug development
Research and development of new products for others; Technical research in the field of pharmaceutical studies; Research in the field of artificial intelligence technology; Chemical research; Biological research; Culturing of cells for others for scientific research purposes; Drug screening for scientific research purposes; Biomedical research services; Development of computer platforms; Platform as a service (PAAS) featuring computer software platforms for use in biotechnological research, drug discovery and pharmaceutical drug development; Pharmaceutical research and development in the field of mRNA drugs; Laboratory services for biomanufacturing peptides; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for use in biotechnological research, drug discovery and pharmaceutical drug development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in biotechnological research, drug ...
